HERBIOTA-COMPLETE Trademark
Trademark Overview
On Friday, August 9, 2024, a trademark application was filed for HERBIOTA-COMPLETE with the United States Patent and Trademark Office. The USPTO has given the HERBIOTA-COMPLETE trademark a serial number of 98691077. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 4, 2025. This trademark is owned by Heranova Biosciences Inc. The HERBIOTA-COMPLETE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical diagnostic assay test and analysis for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; medical diagnostic assay test and analysis of uterine and vaginal tissue for bacterial, fungal and resistance markers for determining a personalized treatment plan.
Providing medical information in the field of gynecology; medical information services in the gynecological field, namely endometritis; medical diagnostic services for gynecological conditions; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely testing services for detecting endometritis, Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility.
General Information
| Serial Number | 98691077 |
| Word Mark | HERBIOTA-COMPLETE |
| Filing Date | Friday, August 9, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, March 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical diagnostic assay test and analysis for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; medical diagnostic assay test and analysis of uterine and vaginal tissue for bacterial, fungal and resistance markers for determining a personalized treatment plan. |
| Goods and Services | Providing medical information in the field of gynecology; medical information services in the gynecological field, namely endometritis; medical diagnostic services for gynecological conditions; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely testing services for detecting endometritis, Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 9, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 9, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Heranova Biosciences Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, MA 01803 |
Trademark Events
| Event Date | Event Description |
| Friday, August 9, 2024 | NEW APPLICATION ENTERED |
| Monday, February 24, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 25, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, March 4, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 4, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 4, 2025 | NON-FINAL ACTION E-MAILED |
